Journal of the National Cancer Institute
Re: Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer.
Steven Lehrer
Published: 202610.1093/jnci/djaf339
No abstract available for this study.